Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+65.3%
5Y CAGR+60.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+65.3%/yr
vs +58.8%/yr prior
5Y CAGR
+60.4%/yr
Recent acceleration
Acceleration
+6.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.6x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $191.33M | +91.8% |
| 2024 | $99.74M | +71.7% |
| 2023 | $58.09M | +37.0% |
| 2022 | $42.39M | +72.9% |
| 2021 | $24.52M | +36.1% |
| 2020 | $18.03M | +33.3% |
| 2019 | $13.52M | +103.0% |
| 2018 | $6.66M | +243.4% |
| 2017 | $1.94M | +26.5% |
| 2016 | $1.53M | - |